Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors
Clinical trial NCT01496534 · TERMINATED
Trial details
- NCT number
- NCT01496534
- Sponsor
- Matthew Galsky
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2013-09-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.